West Pharmaceutical Servi... (WST)
NYSE: WST
· Real-Time Price · USD
260.62
6.14 (2.41%)
At close: Sep 26, 2025, 11:02 AM
2.41% (1D)
| Bid | 259.39 |
| Market Cap | 18.74B |
| Revenue (ttm) | 2.96B |
| Net Income (ttm) | 487.7M |
| EPS (ttm) | 6.68 |
| PE Ratio (ttm) | 39.01 |
| Forward PE | 34.27 |
| Analyst | Buy |
| Dividends | $1.06 |
| Ask | 260.68 |
| Volume | 83,173 |
| Avg. Volume (20D) | 700,666.8 |
| Open | 254.99 |
| Previous Close | 254.48 |
| Day's Range | 254.76 - 260.62 |
| 52-Week Range | 187.43 - 352.33 |
| Beta | 1.05 |
| Ex-Dividend Date | Nov 12, 2025 |
Analyst Forecast
According to 0 analyst ratings, the average rating for WST stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsWest Pharmaceutical Services Inc. is scheduled to release its earnings on
Oct 23, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago
+22.78%
West Pharmaceutical shares are trading higher afte...
Unlock content with
Pro Subscription
5 months ago
-3.48%
West Pharmaceutical Services shares are trading lower after the company reported Q1 financial results and cut its FY25 EPS guidance with its midpoint below estimates.
2 months ago · seekingalpha.com
West Pharmaceutical Services: Low Debt, High Profit, And A Waning Destocking ProblemMy estimations suggest that the U.S. government cuts to its healthcare system will not have a significant negative impact on West Pharmaceutical's revenues. In Q2 2025, the company's revenues increase...